An expanded 75-color panel of Pdots for spectral multiplexing
用于光谱复用的扩展 75 色 Pdot 面板
基本信息
- 批准号:10761598
- 负责人:
- 金额:$ 49.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AntibodiesAutoimmune DiseasesB-LymphocytesBasic ScienceBiological MarkersCD8-Positive T-LymphocytesCell CycleCellsCellular AssayClinicalColorCommunicable DiseasesCompensationCouplingDendritic CellsDevelopmentDiagnosisDiagnostic testsDiseaseDyesEnergy TransferEnsureExhibitsFamilyFingerprintFlow CytometryFluorescent DyesFluorescent ProbesFluorochromeFutureHistopathologyHumanImmuneImmune responseImmunophenotypingLabelLasersMainstreamingMalignant NeoplasmsMeasuresMetabolicMethodsNatural Killer CellsNatureOpticsPamphletsParticle SizePolymersPopulationProteinsQuantum DotsReactionRegulatory T-LymphocyteResearch PersonnelResolutionSeriesSignal TransductionSortingSourceSystemT-LymphocyteTechniquesTechnologyTimeTissue imagingTranslational ResearchValidationVertebral columnWidthantibody conjugatecancer therapycell analyzerclinical diagnosticscommercializationdesigndetection platformdetectordiagnostic assaydiagnostic panelexperimental studyfluorophoreimprovedinstrumentmonocytemonomermultiplexed imagingnanoparticleperipheral bloodpersonalized medicinepreservationpublic health relevanceultraviolet
项目摘要
Project Summary
Flow cytometry is widely used in basic and translational research and in clinical diagnostic assays. Spectral flow
cytometry represents a revolutionary change in the approach to flow cytometry by using full spectral information
from each fluorophore—by collecting the emission over the full spectrum and using multiple excitation sources
for each fluorophore to obtain a spectral “signature” or “fingerprint”. The resulting spectral signature is used in
automated spectral unmixing that is simpler and more effective than current compensation methods. As a result,
even fluorophores with highly overlapping spectra can be used simultaneously, simplifying panel construction
and enlarging the maximum panel size; subtraction of cell autofluorescence is also improved. These factors
combine to allow greater resolution of cell subpopulations. In addition, hardware can be simplified since a
particular configuration of filter sets is not needed for a particular set of dyes. Spectral flow cytometry has
progressed to the mainstream, with several commercial spectral flow systems now available (Cytek Aurora, Sony
ID7000, BD Symphony A5 SE, Thermo Bigfoot).
However, the development of dyes has not kept pace with the development of spectral flow systems. For
example, Sony’s ID7000 system includes a 320 nm excitation source for which no dyes have been specifically
developed. We and others have developed a new family of ultrabright fluorescent nanoparticles called Pdots,
which are semiconducting polymers collapsed into 5–30 nm (tunable size) nanoparticles. Pdots are bright and
photostable, and are unique in exhibiting a long, tunable Stokes shift, enabling the creation of a large color panel.
Here we propose to expand the multi-color panel of Pdots from 37 to 75 by adding 38 new colors,
including a new series of 18 Pdots excited at 320 nm (no previous Pdots have been excitable at 320 nm), as
well as 20 new Pdots excited at 355, 405, 488, 561, and 640 nm, filling gaps between the emission peaks of
existing Pdots with the same excitation while preserving a separation of at least 20 nm between emission peaks
with most emission peaks separated by 30 nm or larger. We will demonstrate the utility of these Pdots in spectral
flow cytometry by developing and validating a 75-parameter panel for deep immunophenotyping of major cell
subsets in human peripheral blood. The 75-color panel of Pdots will also be useful in high multiplex tissue
imaging (e.g., histopathology).
项目摘要
流式细胞术广泛用于基础和转化研究以及临床诊断测定。谱流
流式细胞术代表了通过使用全光谱信息的流式细胞术方法的革命性变化
从每个荧光团-通过收集整个光谱上的发射并使用多个激发源
以获得光谱“特征”或“指纹”。所得到的光谱特征用于
自动光谱分解比当前的补偿方法更简单和更有效。因此,在本发明中,
甚至可以同时使用具有高度重叠光谱的荧光团,简化了面板构造
并且扩大了最大板尺寸;细胞自发荧光的扣除也得到了改善。这些因素
联合收割机以允许更高的细胞亚群分辨率。此外,硬件可以被简化,因为
对于特定的一组染料,不需要过滤器组的特定构造。光谱流式细胞术具有
发展到主流,现在有几种商业光谱流系统可用(Cytek Aurora,Sony
ID7000,BD Symphony A5 SE,Thermo Bigfoot)。
然而,染料的发展并没有跟上光谱流系统的发展。为
例如,Sony的ID 7000系统包括320 nm激发源,对于该激发源没有染料被特别地
开发我们和其他人已经开发出一种新的超亮荧光纳米粒子家族,称为Pdot,
其是塌陷成5-30 nm(可调尺寸)纳米颗粒的半导体聚合物。Pdot是明亮的,
这种材料是光稳定的,并且在表现出长的、可调的斯托克斯位移方面是独特的,从而能够产生大的彩色面板。
在这里,我们建议通过添加38种新颜色来将Pdot的多色面板从37扩展到75,
包括在320 nm处激发的新的一系列18个Pdot(没有先前的Pdot在320 nm处可激发),
以及在355、405、488、561和640 nm处激发的20个新的Pdot,填充了
具有相同激发的现有Pdot,同时在发射峰之间保持至少20 nm的间隔
大多数发射峰相隔30 nm或更大。我们将展示这些Pdot在光谱分析中的实用性。
通过开发和验证用于主要细胞的深度免疫表型分析的75个参数面板的流式细胞术
人外周血中的亚群。Pdot的75色面板也将在高度多重组织中有用
成像(例如,组织病理学)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiangbo Yu其他文献
Jiangbo Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiangbo Yu', 18)}}的其他基金
Significant expansion of spectral multiplexing in PCR
PCR 中光谱多重功能的显着扩展
- 批准号:
10698894 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Pdot-Enabled Point-of-Care Digital PCR for Sensitive Detection of SARS-CoV-2
支持 Pdot 的床旁数字 PCR 用于 SARS-CoV-2 的灵敏检测
- 批准号:
10165078 - 财政年份:2017
- 资助金额:
$ 49.96万 - 项目类别:
Ultra-Bright Fluorescent Probes for Flow Cytometry
用于流式细胞术的超亮荧光探针
- 批准号:
9753286 - 财政年份:2017
- 资助金额:
$ 49.96万 - 项目类别:
Semiconducting Polymer Dots for Multiplexed Assays
用于多重检测的半导体聚合物点
- 批准号:
9141866 - 财政年份:2014
- 资助金额:
$ 49.96万 - 项目类别:
Semiconducting Polymer Dots for Multiplexed Assays
用于多重检测的半导体聚合物点
- 批准号:
8646764 - 财政年份:2014
- 资助金额:
$ 49.96万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 49.96万 - 项目类别: